"prostate tumor progression" trang 10 - tải miễn phí từ tailieunhanh
Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy

Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy
8    59    1
Partnering around cancer clinical trials (PACCT): Study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials

Partnering around cancer clinical trials (PACCT): Study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials
12    93    1
Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5

Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5
12    43    1
Can you un-ring the bell? A qualitative study of how affect influences cancer screening decisions

Can you un-ring the bell? A qualitative study of how affect influences cancer screening decisions
14    42    1
The outcome of prostate cancer patients treated with curative intent strongly depends on survival after metastatic progression

The outcome of prostate cancer patients treated with curative intent strongly depends on survival after metastatic progression
8    61    1
Tissue microarray analysis indicates hedgehog signaling as a potential prognostic factor in intermediate-risk prostate cancer

Tissue microarray analysis indicates hedgehog signaling as a potential prognostic factor in intermediate-risk prostate cancer
7    92    1
Follow-up care after treatment for prostate cancer: Protocol for an evaluation of a nurse-led supported self-management and remote surveillance programme

Follow-up care after treatment for prostate cancer: Protocol for an evaluation of a nurse-led supported self-management and remote surveillance programme
10    65    1
Does hair dye use really increase the risk of prostate cancer?

Does hair dye use really increase the risk of prostate cancer?
5    34    1
Enzalutamide versus abiraterone as a first-line endocrine therapy for castrationresistant prostate cancer (ENABLE study for PCa): A study protocol for a multicenter randomized phase III trial

Enzalutamide versus abiraterone as a first-line endocrine therapy for castrationresistant prostate cancer (ENABLE study for PCa): A study protocol for a multicenter randomized phase III trial
6    68    1
Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma

Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma
21    70    1
Detection of circulating miRNAs: Comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients

Detection of circulating miRNAs: Comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients
13    35    1
Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancer

Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancer
8    91    1
Testosterone inhibits the growth of prostate cancer xenografts in nude mice

Testosterone inhibits the growth of prostate cancer xenografts in nude mice
6    83    1
An agent-based model of prostate Cancer bone metastasis progression and response to Radium223

An agent-based model of prostate Cancer bone metastasis progression and response to Radium223
19    50    1
Real-world efficacy and safety of two doses of cabazitaxel (20 or 25 mg/m2 ) in patients with castration-resistant prostate cancer: Results of a Japanese post-marketing surveillance study

Real-world efficacy and safety of two doses of cabazitaxel (20 or 25 mg/m2 ) in patients with castration-resistant prostate cancer: Results of a Japanese post-marketing surveillance study
11    53    1
Development of a computer-tailored physical activity intervention for prostate and colorectal cancer patients and survivors: OncoActive

Development of a computer-tailored physical activity intervention for prostate and colorectal cancer patients and survivors: OncoActive
19    44    1
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
9    33    1
Metformin and longevity (METAL): A window of opportunity study investigating the biological effects of metformin in localised prostate cancer

Metformin and longevity (METAL): A window of opportunity study investigating the biological effects of metformin in localised prostate cancer
12    47    1
Proteomic characterization of paired nonmalignant and malignant African-American prostate epithelial cell lines distinguishes them by structural proteins

Proteomic characterization of paired nonmalignant and malignant African-American prostate epithelial cell lines distinguishes them by structural proteins
18    57    1
UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression

UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression
8    29    1